SLC5A2 and diabetes mellitus: The clinical relevance of increased proximal reabsorption and hyperfiltration in diabetes has been demonstrated by the ability of SGLT2 inhibitors (SGLT2is) to improve renal outcomes in patients with diabetes in large-scale clinical trials, promoting the emergence of the renal tubulocentric hypothesis (15).